Log In Sign Up Premium
#1 AI Stock to Buy
  • Markets
    • News
    • Tech
    • Market Movers
    • Futures Forex
    • Macroeconomic Predictions
    • Economy
    • Industries
    • Options
  • Insider Trading
    • Main
    • Education Center
    • Insider Trading Screener
    • Insider Purchases
    • Insider Sales
    • Browse Companies
    • Transcripts
    • Latest 13D & 13G Filings
  • Hedge Funds
    • Main
    • Education Center
    • Browse Hedge Funds
    • Investor Letters
    • Best Performing
    • Worst Performing
    • Other Institutional Investors
  • Retirement
    • ETF Trading
    • Commodities
    • Gold
    • Dividend Stocks
  • Opinion
    • Main
    • Hedge Fund Analysis
    • Stock Analysis
    • We Disagree
    • Lists
    • Authors
  • Premium
    • Newsletters
    • My Subscriptions
    • Premium Readership
  • Log In
  • Sign Up

Our #1 AI Stock Pick — 33% OFF: $9.99 (was $14.99)  Monthly picks · Ad-free browsing · 30-day money back guarantee

Our #1 AI Stock Pick — 33% OFF: $9.99 (was $14.99)  Monthly picks · Ad-free browsing

Unlock Now — $9.99
Companies 0 See All
Hedge Funds 0 See All
Insiders 0 See All
Institutional Investors 0 See All
Click here to see all results for Sorry, no results has been found matching your query.

Insider Monkey Blog

Zegna’s (ZGN) Direct Sales Surge Can’t Fully Offset A Messier Profit

On September 3, Ermenegildo Zegna Group (NYSE:ZGN) reported first-half revenues of €987.3 million, up 6.4% year over year and 9.3% on an organic basis.

Keep Reading →

September 4 - Hedge Funds, News

Revolution Med (RVMD) Priced Rasonque at $39,800 per 30-Day Supply. Can Access Match the Clinical Breakthrough?

Revolution Medicines, Inc. (NASDAQ:RVMD) received FDA approval for Rasonque, or daraxonrasib, following an expedited review.

Keep Reading →

September 4 - Hedge Funds, News

Hormel (HRL) Expanded Adjusted Operating Margin Despite a Volume Decline. Can Cost Savings Carry the Turnaround?

Hormel Foods Corporation (NYSE:HRL) reported fiscal third-quarter sales of $2.96 billion, down 2.4%, as volume declined 7.4% and organic net sales fell 1.7%.

Keep Reading →

September 4 - Hedge Funds, News

Murphy Oil (MUR) Strikes Black Gold While Profits Multiply Tenfold

On August 5, Murphy Oil Corporation (NYSE:MUR) reported second-quarter results that showed the company hitting on nearly every cylinder at once.

Keep Reading →

September 4 - Hedge Funds, News

Science Applications (SAIC) Grew Revenue 6% but Posted a 0.6 Book-to-Bill Ratio. Is the $22B Backlog Enough?

Science Applications International Corporation (NASDAQ:SAIC) reported second-quarter fiscal 2027 revenue of $1.88 billion, up 6.3% year over year.

Keep Reading →

September 4 - Hedge Funds, News

GameStop (GME) Plans to Use $358M of Cash to Reduce Dilution in Its Note Exchange. Is Liquidity Being Put to Better Use?

GameStop Corp. (NYSE:GME) amended its agreement to exchange approximately $1.4 billion of convertible senior notes due in 2030 and 2032.

Keep Reading →

September 4 - Hedge Funds, News

Salesforce (CRM) Grew Agentforce and Data 360 ARR More Than 200%. Is AI Finally Becoming Material to Growth?

Salesforce, Inc. (NYSE:CRM) reported fiscal 2027 second-quarter revenue of $11.345 billion, up 11% year over year.

Keep Reading →

September 4 - Hedge Funds, News

Aon (AON) is Paying $17B for USI. Can $395M of Synergies Justify Another Debt-Funded Megadeal?

Aon plc (NYSE:AON) agreed to acquire USI Insurance Services for $17 billion in cash, subject to downward adjustments for specified leakage since June 30, 2026.

Keep Reading →

September 4 - Hedge Funds, News

BioMarin (BMRN) Secured 20% U.S. Royalties on Yuviwel. Is Monetizing a Rival Better than Blocking It?

BioMarin Pharmaceutical Inc.

Keep Reading →

September 4 - Hedge Funds, News

BridgeBio (BBIO) Reported Signs of Cardiac Reversal With Acoramidis. How Much Weight Should Investors Give a Completer Analysis?

BridgeBio Pharma, Inc. (NASDAQ:BBIO) is asking investors to look beyond disease stabilization in transthyretin amyloid cardiomyopathy, or ATTR-CM.

Keep Reading →

September 4 - Hedge Funds, News

Arrowhead (ARWR) Reported a 78% Lower Pancreatitis Event Rate With Plozasiran. Does the Absolute Benefit Support a Broader Label?

Arrowhead Pharmaceuticals, Inc.

Keep Reading →

September 4 - Hedge Funds, News

MIMRYLO Approval Triggered $275M Payments for Protagonist (PTGX). Are Royalties the Better Commercial Model?

U.S.

Keep Reading →

September 4 - Hedge Funds, News

Teva (TEVA) Backed a Bid of Up to $125M in Cash Plus Assumed Liabilities for BioXcel’s Assets. Is Bankruptcy-Sale Risk Worth the At-Home Opportunity?

Teva Pharmaceuticals International GmbH, a subsidiary of Teva Pharmaceutical Industries Limited (NYSE:TEVA), agreed to serve as the stalking-horse bidder for substantially all...

Keep Reading →

September 4 - Hedge Funds, News

Amgen (AMGN) Says Repatha Reduced Mortality Before a First Heart Attack or Stroke. Can Earlier Use Expand the Market?

Amgen Inc. (NASDAQ:AMGN) reported that Repatha reduced the risk of all-cause mortality by 20% in a prespecified secondary analysis of the Phase 3 VESALIUS-CV trial.

Keep Reading →

September 4 - Hedge Funds, News

PU Prime Launches Australian Operations under ASIC Licence

SYDNEY, AUSTRALIA, September 4th, 2026, FinanceWire PU Prime officially launches operations in Australia through its ASIC-regulated local entity, PU Prime Trading Pty Ltd.

Keep Reading →

September 4 - Press Releases

IUX Announces Two New Podcast Series: IUX Market Trendline and The Market Journey

Ebene Cybercity, Mauritius, September 4th, 2026, FinanceWire IUX has announced the two new podcast series, IUX Market Trendline and The Market Journey, expanding its educational...

Keep Reading →

September 4 - Press Releases

Algonquin (AQN) is Selling its Chilean Water Stake for $126.5M. Will Simplification Improve Returns?

Algonquin Power & Utilities Corp. (NYSE:AQN) agreed to sell its approximately 64% interest in Chilean water utility Suralis S.A. to a fund managed by Toesca S.A.

Keep Reading →

September 4 - Hedge Funds, News

Hedge Fund Investor Letters Q2 2026

In this article, we will share the hedge fund investor letters for the second quarter of 2026.

Keep Reading →

September 4 - Hedge Fund Investor Letters, News

Ballard Power (BLDP) Bought GeoPura at an Enterprise Value of About $400M. Can Recurring Revenue Justify the 14% Pro Forma Stake?

Ballard Power Systems Inc. (NASDAQ:BLDP) completed its acquisition of GeoPura Limited on August 28, 2026.

Keep Reading →

September 4 - Hedge Funds, News

Energy Fuels (UUUU) Added Rare-Earth Alloy Production for About $243M. Can it Execute a Mine-to-Magnet Strategy?

Energy Fuels Inc. (NYSEAmerican:UUUU) completed its acquisition of Australian Strategic Materials, adding an operating metal and alloy business to its rare-earth portfolio.

Keep Reading →

September 4 - Hedge Funds, News

PG&E (PCG) Sub Says California’s Wildfire Bill Leaves Financing Risk Unresolved. What Protection Is Still Missing?

Pacific Gas and Electric Company, the regulated utility subsidiary of PG&E Corporation (NYSE:PCG), said California Senate Bill 492 would improve wildfire-survivor recovery and...

Keep Reading →

September 4 - Hedge Funds, News

Aurora Innovation (AUR) Partners with McLane Company to Launch Driverless Commercial Hauls

Meridian Funds, managed by ArrowMark Partners, released its second-quarter 2026 investor letter for “Meridian Hedged Equity Fund”. The letter can be downloaded here. U.S.

Keep Reading →

September 4 - Hedge Fund Investor Letters, News

Acquisition Premium Injects Immediate Boost into MGM Resorts International (MGM) Shares

Meridian Funds, managed by ArrowMark Partners, released its second-quarter 2026 investor letter for “Meridian Hedged Equity Fund”. The letter can be downloaded here. U.S.

Keep Reading →

September 4 - Hedge Fund Investor Letters, News

Robust Results and Share Repurchase Authorization Boosted ACV Auctions (ACVA)

Meridian Funds, managed by ArrowMark Partners, released its second-quarter 2026 investor letter for “Meridian Hedged Equity Fund”. The letter can be downloaded here. U.S.

Keep Reading →

September 4 - Hedge Fund Investor Letters, News

Here’s What Pressured Intercontinental Exchange (ICE)

Meridian Funds, managed by ArrowMark Partners, released its second-quarter 2026 investor letter for “Meridian Hedged Equity Fund”. The letter can be downloaded here. U.S.

Keep Reading →

September 4 - Hedge Fund Investor Letters, News

Southern Co (SO) Cleared PSC Review for 3.2GW of OpenAI Demand. Can Data Centers Lower Customer Bills Without Raising Grid Risk?

The Southern Company (NYSE:SO) cleared the Georgia Public Service Commission review process for Georgia Power to serve an OpenAI data center project in Effingham County, Georgia...

Keep Reading →

September 4 - Hedge Funds, News

GLOBALFOUNDRIES (GFS) Surged on Robust CID Growth and Dividend Announcement

Meridian Funds, managed by ArrowMark Partners, released its second-quarter 2026 investor letter for “Meridian Hedged Equity Fund”. The letter can be downloaded here. U.S.

Keep Reading →

September 4 - Hedge Fund Investor Letters, News

ONEOK (OKE) is Funding a $4.4B Acquisition With a $9B Minority Investment. Is the 7% Capped Return Attractive?

ONEOK, Inc. (NYSE:OKE) agreed to acquire Brazos Midstream’s Permian Midland Basin assets for $4.425 billion in cash.

Keep Reading →

September 4 - Hedge Funds, News

High Capital Requirements and Operational Challenges Weighed On Chevron Corporation (CVX)

Meridian Funds, managed by ArrowMark Partners, released its second-quarter 2026 investor letter for “Meridian Hedged Equity Fund”. The letter can be downloaded here. U.S.

Keep Reading →

September 4 - Hedge Fund Investor Letters, News

Meridian Hedged Equity Fund’s Q2 2026 Investor Letter

Meridian Funds, managed by ArrowMark Partners, released its second-quarter 2026 investor letter for “Meridian Hedged Equity Fund”. U.S.

Keep Reading →

September 4 - Hedge Fund Investor Letters, News

Trimble (TRMB) is Enhancing Efficiency with Advanced Operational Solutions

Meridian Funds, managed by ArrowMark Partners, released its second-quarter 2026 investor letter for “Meridian Contrarian Fund”. The letter can be downloaded here. U.S.

Keep Reading →

September 4 - Hedge Fund Investor Letters, News

Meridian Contrarian Fund Cuts California Resources Corp. (CRC) in Anticipation of Downturn

Meridian Funds, managed by ArrowMark Partners, released its second-quarter 2026 investor letter for “Meridian Contrarian Fund”. The letter can be downloaded here. U.S.

Keep Reading →

September 4 - Hedge Fund Investor Letters, News

PDF Solutions (PDFS): Pioneering Yield Improvement in Semiconductor Manufacturing

Meridian Funds, managed by ArrowMark Partners, released its second-quarter 2026 investor letter for “Meridian Contrarian Fund”. The letter can be downloaded here. U.S.

Keep Reading →

September 4 - Hedge Fund Investor Letters, News

Analysing CEVA’s (CEVA) Growth in Neural Processing Markets

Meridian Funds, managed by ArrowMark Partners, released its second-quarter 2026 investor letter for “Meridian Contrarian Fund”. The letter can be downloaded here. U.S.

Keep Reading →

September 4 - Hedge Fund Investor Letters, News

Concerns Over Defense Spending Weighed on CACI International Inc (CACI)

Meridian Funds, managed by ArrowMark Partners, released its second-quarter 2026 investor letter for “Meridian Contrarian Fund”. The letter can be downloaded here. U.S.

Keep Reading →

September 4 - Hedge Fund Investor Letters, News

The Comeback Story: BlackBerry Limited’s (BB) QNX and Growth Potential

Meridian Funds, managed by ArrowMark Partners, released its second-quarter 2026 investor letter for “Meridian Contrarian Fund”. The letter can be downloaded here. U.S.

Keep Reading →

September 4 - Hedge Fund Investor Letters, News

Meridian Contrarian Fund’s Q2 2026 Investor Letter

Meridian Funds, managed by ArrowMark Partners, released its second-quarter 2026 investor letter for “Meridian Contrarian Fund”. U.S.

Keep Reading →

September 4 - Hedge Fund Investor Letters, News

Diamond Hill Bets on BioLife Solutions’ (BLFS) High Switching Cost

Diamond Hill Capital, a First Eagle Investment Management company, issued its Q2 2026 investor letter for its “Small Cap Strategy”. The letter can be downloaded here.

Keep Reading →

September 4 - Hedge Fund Investor Letters, News

Diamond Hill Stays Focused on Silvercrest (SAMG) Despite Profitability Pressures 

Diamond Hill Capital, a First Eagle Investment Management company, issued its Q2 2026 investor letter for its “Small Cap Strategy”. The letter can be downloaded here.

Keep Reading →

September 4 - Hedge Fund Investor Letters, News

Why FreightCar America (RAIL) Could Benefit as North America’s Railcar Fleet Gets Older 

Diamond Hill Capital, a First Eagle Investment Management company, issued its Q2 2026 investor letter for its “Small Cap Strategy”. The letter can be downloaded here.

Keep Reading →

September 4 - Hedge Fund Investor Letters, News

Why Westend Capital’s Opted Out of the Space Exploration Technologies Corp. (SPCX) IPO

WestEnd Capital Management, an investment advisor, released its Q2 2026 investor letter. The letter can be downloaded here.

Keep Reading →

September 4 - Hedge Fund Investor Letters, News

Scale, Store Footprint, and Same-Day Delivery Drive Target’s (TGT) Competitive Edge

WestEnd Capital Management, an investment advisor, released its Q2 2026 investor letter. The letter can be downloaded here.

Keep Reading →

September 4 - Hedge Fund Investor Letters, News

Potential Earnings Upside Strengthens RH (RH)

WestEnd Capital Management, an investment advisor, released its Q2 2026 investor letter. The letter can be downloaded here.

Keep Reading →

September 4 - Hedge Fund Investor Letters, News

Unique Payer Network Strengthens InfuSystem (INFU)

Diamond Hill Capital, a First Eagle Investment Management company, issued its Q2 2026 investor letter for its “Small Cap Strategy”. The letter can be downloaded here.

Keep Reading →

September 4 - Hedge Fund Investor Letters, News

Diamond Hill Sees Insteel (IIIN) as a Hidden Winner From Infrastructure and Data Center Growth 

Diamond Hill Capital, a First Eagle Investment Management company, issued its Q2 2026 investor letter for its “Small Cap Strategy”. The letter can be downloaded here.

Keep Reading →

September 4 - Hedge Fund Investor Letters, News

Diamond Hill Sees Daktronics (DAKT) as a Turnaround Opportunity With a Strong Balance Sheet 

Diamond Hill Capital, a First Eagle Investment Management company, issued its Q2 2026 investor letter for its “Small Cap Strategy”. The letter can be downloaded here.

Keep Reading →

September 4 - Hedge Fund Investor Letters, News

Billionaire Daniel Loeb Is Betting on These 2 Non-AI Stocks

Billionaire Daniel Loeb’s Third Point opened about 16 new positions during the second quarter.

Keep Reading →

September 4 - News, Stock Analysis

The Bank of New York Mellon Corp. (BNY): Here’s Why Gabelli Likes This Financial Stock

Gabelli Investment Management Firm recently released its “Equity Income Fund” second-quarter 2026 investor letter. A copy of the letter can be downloaded here.

Keep Reading →

September 4 - Hedge Fund Investor Letters, News

Chevron Corp. (CVX): Here’s Why Gabelli Remains Bullish on the Energy Stock

Gabelli Investment Management Firm recently released its “Equity Income Fund” second-quarter 2026 investor letter. A copy of the letter can be downloaded here.

Keep Reading →

September 4 - Hedge Fund Investor Letters, News

Genuine Parts Co. (GPC): Here’s Why Gabelli Sees Value in This Auto Parts Stock

Gabelli Investment Management Firm recently released its “Equity Income Fund” second-quarter 2026 investor letter. A copy of the letter can be downloaded here.

Keep Reading →

September 4 - Hedge Fund Investor Letters, News

« Older Entries
Hedge Fund Resource Center Hedge Fund Resource Center
  • How to Best Use Insider Monkey to Increase Your Returns
  • Why Track Hedge Funds?
  • Download a Free Edition!
  • Why You Should DUMP Your Hedge Funds
  • 6 Things You Didn't Know About Hedge Funds
Hot Topics

Apple (AAPL)

Latest Stock News - Company Profile

Warren Buffett

News & Analysis - Portfolio & Stock Picks

Biggest Insider Purchases & Sales

News & Analysis - Data Screener

Google (GOOG)

Latest Stock News - Company Profile

Microsoft (MSFT)

Latest Stock News - Company Profile

Lists

11 Largest Uranium Producing Countries in the World

11 Largest Uranium Producing Countries in the World

12 Fastest Declining Economies in the World in 2026

12 Fastest Declining Economies in the World in 2026

10 Most Popular Stocks on Robinhood in 2026

10 Most Popular Stocks on Robinhood in 2026

9 Undervalued Chemical Stocks to Buy According to Hedge Funds

9 Undervalued Chemical Stocks to Buy According to Hedge Funds

7 Most Promising Psychedelic Stocks According to Hedge Funds

7 Most Promising Psychedelic Stocks According to Hedge Funds

7 Cheap Pharmaceutical Stocks to Buy According to Hedge Funds

7 Cheap Pharmaceutical Stocks to Buy According to Hedge Funds

15 Innovative Healthcare Stocks to Buy According to Analysts

15 Innovative Healthcare Stocks to Buy According to Analysts

9 High Growth Small Cap Stocks That Are Profitable

9 High Growth Small Cap Stocks That Are Profitable

20 Most Profitable Stocks of the Last 20 Years

20 Most Profitable Stocks of the Last 20 Years

15 High Growth Mid-Cap Stocks to Buy

15 High Growth Mid-Cap Stocks to Buy

Top 10 Oncology Stocks to Buy Now

Top 10 Oncology Stocks to Buy Now

10 Best Investments During A Recession

10 Best Investments During A Recession

7 Best Rare Earth Stocks to Buy According to Hedge Funds

7 Best Rare Earth Stocks to Buy According to Hedge Funds

Barclays Turns More Bullish on 10x Genomics, Inc. (TXG) Despite Uneven Research Spending

Barclays Turns More Bullish on 10x Genomics, Inc. (TXG) Despite Uneven Research Spending

New Product Launch Strengthens Bull Case for Twist Bioscience ( TWST)

New Product Launch Strengthens Bull Case for Twist Bioscience ( TWST)

J.P. Morgan Lifts Natera, Inc. (NTRA) Target on Signatera Momentum

J.P. Morgan Lifts Natera, Inc. (NTRA) Target on Signatera Momentum

11 Best Cancer Stocks to Buy Right Now

11 Best Cancer Stocks to Buy Right Now

Moderna, Inc. (MRNA) Reports Strong H5 Avian Flu Vaccine Data Despite HHS Funding Cut

Moderna, Inc. (MRNA) Reports Strong H5 Avian Flu Vaccine Data Despite HHS Funding Cut

20 Countries with the Highest Homeless Population

20 Countries with the Highest Homeless Population

12 Countries with the Highest Bond Yields in the World

12 Countries with the Highest Bond Yields in the World

20 Countries with the Most Battle Tanks in the World

20 Countries with the Most Battle Tanks in the World

12 Best Nasdaq Stocks Under $20 to Buy Now

12 Best Nasdaq Stocks Under $20 to Buy Now

10 Best Low Beta Tech Stocks to Buy According to Analysts

10 Best Low Beta Tech Stocks to Buy According to Analysts

10 Worst Performing Currencies of 2024

10 Worst Performing Currencies of 2024

16 Countries with the Largest Proven Oil Reserves in the World

16 Countries with the Largest Proven Oil Reserves in the World

16 Highest Quality Chocolate Brands in the US

16 Highest Quality Chocolate Brands in the US

20 Countries with the Strongest Armies in the World

20 Countries with the Strongest Armies in the World

Top 13 English Speaking Countries in Asia

Top 13 English Speaking Countries in Asia

20 States with Highest Female to Male Ratio in the US

20 States with Highest Female to Male Ratio in the US

20 States with the Lowest Life Expectancy in the US

20 States with the Lowest Life Expectancy in the US

25 Cities with the Highest Homeless Population in the World

25 Cities with the Highest Homeless Population in the World

30 Cities with the Highest Weed Consumption in the US

30 Cities with the Highest Weed Consumption in the US

25 Countries with the Highest Alcohol Consumption per Capita

25 Countries with the Highest Alcohol Consumption per Capita

10 Best Gold Stocks Under $30

10 Best Gold Stocks Under $30

10 Best Genomics Stocks To Buy Right Now

10 Best Genomics Stocks To Buy Right Now

Get our editor’s daily picks straight in your inbox!

RSS Feed Hedge Funds Insider Trading About Us Authors Contact Us Sitemap
Privacy Policy Terms of Use Disclosure Policy FAQ CCPA - Do Not Sell My Information. ©2026 Koala Guide LLC.